This study examined the effects of midazolam on circulating concentrations of blood glucose and cardiovascular response and compaired with a comparable group of patients receiving thiopental as induction agent only. Twenty patients of ASA class 1 were...
This study examined the effects of midazolam on circulating concentrations of blood glucose and cardiovascular response and compaired with a comparable group of patients receiving thiopental as induction agent only. Twenty patients of ASA class 1 were randomly allocated to Control or Midazolam group.
Blood glucose level in reponse to anesthesia and surgery were comparable in the two groups of patients. The use of midazolam as premedicant (0.05 mg/kg, intramuscularly) and intravenous induction agent (0.3 mg/kg) was not associated with significant increase in blood glucose and mean arterial pressure.